The design of our phase 1 study was only designed for stroke patients not TBI
Phase 1 is to determine not only safety but also dose concentrations for that specific condition. You don’t just go into phase 2 guessing the dose we want to give. Phase 1 determines that and through blood markers
Looking back at our announcements it was all designed for stroke.
- Forums
- ASX - By Stock
- AGN
- AGN Media thread
AGN Media thread, page-127
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGN (ASX) to my watchlist
|
|||||
Last
86.5¢ |
Change
0.055(6.79%) |
Mkt cap ! $105.5M |
Open | High | Low | Value | Volume |
82.5¢ | 86.5¢ | 81.0¢ | $114.4K | 136.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 15463 | 85.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
86.5¢ | 32000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 15463 | 0.850 |
1 | 2800 | 0.835 |
1 | 6024 | 0.830 |
2 | 12854 | 0.825 |
1 | 10000 | 0.820 |
Price($) | Vol. | No. |
---|---|---|
0.865 | 32000 | 1 |
0.870 | 8000 | 1 |
0.880 | 116 | 1 |
0.890 | 5000 | 1 |
0.895 | 4022 | 1 |
Last trade - 12.42pm 12/08/2024 (20 minute delay) ? |
Featured News
AGN (ASX) Chart |